[1]叶惠珍. β1受体阻断剂盐酸兰地洛尔[J]. 世界临床药物, 2004, 25(3): 189190.
[2]赫冠男, 吕黄伟, 王俊科. 兰地洛尔的药理作用及其围手术期的应用[J]. 中国新药与临床杂志, 2007, 26(12): 942945.
[3]庾莉菊, 黄海伟, 李秀梅, 等. 超高效合相色谱法测定盐酸兰地洛尔中立体异构体的含量[J]. 分析化学, 2016, 44(9): 13481353.
[4] 卢定强, 李衍亮, 凌岫泉, 等. 手性药物拆分技术的研究进展[J]. 时珍国医国药, 2009, 20 (7): 17311734.
[5] 张倩, 冯明声, 曹于平, 等.超短效 β1肾上腺素受体阻断剂:盐酸兰地洛尔的研发和临床应用[J].中国医药指南,2012, 10(9): 79.
[6] KIDO T, MOCHIZUKI T, HIRANO M, et al. Radiationdoselowering effects of landiolol hydrochloride in coronary angiography using computed tomography (Delight):A prospective multicenter study[J].Circ J, 2016,80(5):12251231.
[7] 李梅, 孙政, 庄儒麟, 等.兰地洛尔和艾司洛尔抗实验性心律失常作用和安全性评价的比较研究[J].中国临床药理学杂志, 2015, 31(8): 640644.
[8]SAKANASHI M, SAKANASHI M,SUGAHARA K, et al. Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts[J]. Clin Exp Pharmacol Physiol, 2007, 34(1/2): 5560.
[9] YU SC, KATOH T, OKADA H, et al. Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts[J]. J Anesth, 2010, 24(2): 208214.
[10] KAWAGUCHI M, KAWARAGUCHI Y, YAMAMOTO Y, et al. Effects of landiolol on systemic and cerebral hemodynamics and recovery from anesthesia in patients undergoing craniotomy[J]. J Anesth, 2010, 24(4): 503510.
[11] GOTO K,SHINGU C,MIYAMOTO S,et al.The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease[J]. J Clin Anesth,2007,19(7):523529.
[12]KADOI Y,HORIUCHI T,UCHIDA S,et al.A dequacy of control of preoperative hypertension can affect landiololinduced hemodynamic changes in elderly patients during emergence from anesthesia[J]. J Anesth, 2011, 25(2): 271277.
[13]梁键谋, 傅聪, 陈悦. LCMS/MS 测定草酸右旋西酞普兰中对甲苯磺酸酯类基因毒性杂质的含量[J].中国现代应用药学, 2016, 33 (11):14361440.
[14]周长朋, 王东武, 张曼玉, 等. 高效液相色谱四极杆/线性离子阱质谱仪测定盐酸决奈达隆中两种基因毒性杂质的痕量残留[J]. 分析测试学报, 2016, 35 (9):11111115. |